PH31255A - Use of triazine compounds as anxiolytics. - Google Patents

Use of triazine compounds as anxiolytics.

Info

Publication number
PH31255A
PH31255A PH47945A PH47945A PH31255A PH 31255 A PH31255 A PH 31255A PH 47945 A PH47945 A PH 47945A PH 47945 A PH47945 A PH 47945A PH 31255 A PH31255 A PH 31255A
Authority
PH
Philippines
Prior art keywords
anxiolytics
triazine compounds
triazine
compounds
Prior art date
Application number
PH47945A
Other languages
English (en)
Inventor
Critchley Martyn Alan Edwin
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of PH31255A publication Critical patent/PH31255A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH47945A 1993-03-19 1994-03-18 Use of triazine compounds as anxiolytics. PH31255A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939305692A GB9305692D0 (en) 1993-03-19 1993-03-19 Therapeutic triazine compounds and use

Publications (1)

Publication Number Publication Date
PH31255A true PH31255A (en) 1998-06-18

Family

ID=10732357

Family Applications (1)

Application Number Title Priority Date Filing Date
PH47945A PH31255A (en) 1993-03-19 1994-03-18 Use of triazine compounds as anxiolytics.

Country Status (17)

Country Link
US (1) US5658905A (da)
EP (1) EP0689440B1 (da)
JP (1) JP3633618B2 (da)
AP (1) AP464A (da)
AT (1) ATE193446T1 (da)
AU (1) AU6217794A (da)
CY (1) CY2248B1 (da)
DE (1) DE69424779T2 (da)
DK (1) DK0689440T3 (da)
ES (1) ES2147232T3 (da)
GB (1) GB9305692D0 (da)
GR (1) GR3033941T3 (da)
IL (1) IL109035A0 (da)
PH (1) PH31255A (da)
PT (1) PT689440E (da)
WO (1) WO1994021261A1 (da)
ZA (1) ZA941939B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9424766D0 (en) * 1994-12-07 1995-02-08 Wellcome Found Pharmaceutical composition
GB9726987D0 (en) 1997-12-22 1998-02-18 Glaxo Group Ltd Compounds
KR100958291B1 (ko) * 2008-01-23 2010-05-19 한국과학기술연구원 T―타입 칼슘채널을 억제하여 불안 장애를 치료하는 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU182086B (en) * 1979-06-01 1983-12-28 Wellcome Found Process for preparing new 1,2,4-triazine derivatives
DE4118740A1 (de) * 1991-06-05 1992-12-10 Schering Ag Neue kombinationspraeparate zur behandlung des morbus parkinson

Also Published As

Publication number Publication date
GB9305692D0 (en) 1993-05-05
IL109035A0 (en) 1994-06-24
GR3033941T3 (en) 2000-11-30
DK0689440T3 (da) 2000-10-30
JPH08507783A (ja) 1996-08-20
AU6217794A (en) 1994-10-11
AP9400628A0 (en) 1994-04-30
DE69424779T2 (de) 2000-11-02
AP464A (en) 1996-02-20
JP3633618B2 (ja) 2005-03-30
WO1994021261A1 (en) 1994-09-29
ATE193446T1 (de) 2000-06-15
US5658905A (en) 1997-08-19
DE69424779D1 (de) 2000-07-06
EP0689440B1 (en) 2000-05-31
EP0689440A1 (en) 1996-01-03
CY2248B1 (en) 2003-07-04
ES2147232T3 (es) 2000-09-01
PT689440E (pt) 2000-10-31
ZA941939B (en) 1995-09-18

Similar Documents

Publication Publication Date Title
ZA931278B (en) Heterobicyclic compounds
ZA924746B (en) Substituted 1h-3-aryl-pyrrolidine-2,4-dione derivatives
EP0590270A3 (de) Organosilanpolykondensate.
ZA939656B (en) Microvicidal compositions.
ZA92908B (en) Compounds.
EP0598412A3 (de) Hautschutzmittel zum Schutz der menschlichen Haut.
EP0577580A3 (en) Synthesis of sialic conjugates.
EP0649411A4 (en) CONNECTIONS CONTAINING BOR.
EP0671929A4 (en) COMPOSITIONS.
PH31008A (en) Preparation of substituted guanidines.
EP0633771A4 (en) Compounds.
EP0614944A3 (de) Intumeszierende Zusammensetzung vom Zwei-Komponenten-Typ.
ZA938919B (en) Debrominative chlorination of pyrroles.
HU9503962D0 (en) Use of indenoindole compounds
HU9700436D0 (en) Triazine containing anionic compounds useful as antiviral agents
EP0668864A4 (en) SUBSTITUTED BIPHENYLMETHYLIMIDAZOPYRIDINES.
GB2287467B (en) Compounds of the s-triazine series
HU9503281D0 (en) Thioindole pyperidinyl derivatives used as antalgics
EP0629626A3 (en) Cyclopropyl-substituted spiro-photochromic.
GR3026571T3 (en) Preparation of 2-H-heptafluoropropane.
PH31255A (en) Use of triazine compounds as anxiolytics.
GB9320940D0 (en) Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative agents
AU2812692A (en) Processes for the preparation of substituted 1,2,4-triazolo- (1,5-a) (1,3,5)triazines
AU1470497A (en) Triazine containing compounds useful as antiviral agents
GB9301388D0 (en) Lathe